CD8A and severe acute respiratory syndrome: GX-19 induced potent CD4+ and CD8+ T cells in both animal models and it may confer long-lasting immunity against coronaviruses as indicated in SARS survivors, where CD8+ T cell immunity persisted up to 11 years [44,51].